READING, 24th January 2007 – Archimedes Pharma today announces the appointment Simon Collins as UK Country Manager. Reporting directly to Archimedes’ CEO, Richard de Souza, Mr Collins will be responsible for continuing the development and growth of Archimedes’ UK commercial organisation where its current portfolio of specialty products includes Gliadel, localized chemotherapy for high grade glioma0, Zomorph, a leading morphine product for cancer pain, Nozinan, an anti-emetic for cancer patients, and Pabrinex a high potency formulation of vitamins B and C for acute alcohol withdrawal.
